Bridge Life Science Research and Drug Development Landscape Insights
Stay ahead in the competitive landscape with unparalleled access to the latest academic research and drug development landscape data.
Key Benefits
Competitive and Business Intelligence
- Conduct competitive benchmarking to evaluate the strengths and weaknesses of your products compared to competitor products in development.
- Conduct market analysis comprehensively to understand competitive landscapes and identify opportunities for growth and innovation.
- Support cross-regional analyses to compare and contrast research trends and developments across different geographical areas.
Portfolio Strategy and Product Planning
- Assess potential markets for new trends, segmentation, and market attractiveness for new products based on publication literature.
- Identify and assess potential risks associated with each product in the portfolio with respect to market dynamics, latest research, and global drug developments.
- Identify patterns and trends in custom areas to empower faster decision-making backed by data.
Research and Development
- Accelerate R&D processes by using the data, building taxonomies, and organizing knowledge effectively.
- Leverage NLP-based text mining to extract valuable insights from large volumes of text data.
- Create and build knowledge graphs in niche areas to visualize relationships and insights.
Who is this bundle for?
Pharmaceutical Companies
Bio-tech Companies
Life Sciences Corporations
Venture Capital & Investment Firms
Contract Research Organizations (CROs)
Academic Institutions
Government & Regulatory Agencies
Generic & Biosimilar Companies
Research Labs
Contract Development & Manufacturing Organizations (CDMOs)
Consultancies & Agencies
Unlock the Power of Comprehensive Pharmaceutical Data
APIs included in the bundle
Pharma Market Intelligence
AdisInsight APIs
AdisInsight APIs are a collection of APIs that help you retrieve information from the AdisInsight database. Each of our APIs can be seen as building blocks for data integration, data analysis, and insight extraction.
- Drugs API Current development information about the drug that is under investigation around the world updated daily.
- Trials API Latest clinical trial information and summaries of results for drug programs that are in development around the world updated daily.
- Timelines API Access to archive AdisInsight phase of development information dating back to 2004.
AdisInsight is Springer Nature's Pharma database for drug research and development, disease treatment and decision making, based on trusted, scientifically sound data. AdisInsight brings together essential scientific information on drugs in commercial development, key clinical trials, deals, patents and safety profiles, in one easy-to-use database.
More info
Life Sciences & Pharma Research
Full Text API (TDM)
Springer Nature's Full Text API (TDM) offers access to a meticulously curated set of scholarly journals, and articles ensuring broad access to the latest research and insights.
Tap into this rich repository to fuel competitive research in drug discovery, molecular biology, clinical pharmacology, and biotechnology.
- Access to over 3 million articles from over 1,600 journals from Nature, Springer and BMC.
- Over 20 filters to identify on latest discoveries and trends.
- Personalised support from our API experts.
There is an ever-increasing amount of knowledge and data at our fingertips, ready to accelerate new discoveries. The key to unlocking this potential is tools that can select, read and analyze large quantities of text and data and provide the insights you need. At Springer Nature, we provide advanced data solution products to help advance your scientific discoveries and fast-track your innovations.
More info
Transform your drug development pipeline, research & development, and business strategy
Use Cases
Drug Information
Clinical Trial Information
Historical Drug Timeline Information
Return all the drugs being developed by Pfizer that are in clinical development for cancer in the USA utilizing a kinase inhibitor mechanism of action in a small molecule drug class that had an update in 2024.
{
"fromDate": "2024-01-01",
"toDate": "2024-12-31",
"organisations": [
"Pfizer"
],
"phases": [
"Phase III",
"Phase II",
"Phase I"
],
"locations": [
"U S A"
],
"indications": [
"Cancer"
],
"moas": [
"Phosphotransferase inhibitors"
],
"drugClass": [
"Small molecules"
],
"page": 1
}Proven Impact
Access our latest TDM Use Case
How Benevolent AI uses Springer Nature’s journal content and TDM API to assist its artificial intelligence assisted drug discovery process.
White Paper
Bringing Insight to Data: Info Pros’ Role in Text and Data Mining (PDF, 505.29 KB).